These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7667361)
21. Low and high doses of midazolam differentially affect hypoalgesia in rats conditioned to a heat stressor. Harris JA; McGregor IS; Westbrook RF Psychopharmacology (Berl); 1993; 111(1):62-8. PubMed ID: 7870935 [TBL] [Abstract][Full Text] [Related]
22. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats. Li CL; Zhu N; Meng XL; Li YH; Sui N J Psychopharmacol; 2013 Sep; 27(9):837-44. PubMed ID: 23784741 [TBL] [Abstract][Full Text] [Related]
23. Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on "relapse" to opioid drugs. Shaham Y Psychopharmacology (Berl); 1993; 111(4):477-85. PubMed ID: 7870990 [TBL] [Abstract][Full Text] [Related]
24. Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Good AJ; Westbrook RF Behav Neurosci; 1995 Aug; 109(4):631-41. PubMed ID: 7576207 [TBL] [Abstract][Full Text] [Related]
25. Male, but not female, Sprague Dawley rats display enhanced fear learning following acute ethanol withdrawal (hangover). Marsland P; Parrella A; Vore AS; Barney TM; Varlinskaya EI; Deak T Pharmacol Biochem Behav; 2021 Sep; 208():173229. PubMed ID: 34246729 [TBL] [Abstract][Full Text] [Related]
26. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Shoblock JR; Maidment NT Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992 [TBL] [Abstract][Full Text] [Related]
27. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913 [TBL] [Abstract][Full Text] [Related]
28. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Kratzer U; Schmidt WJ Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357 [TBL] [Abstract][Full Text] [Related]
29. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Liu J; Schulteis G Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289 [TBL] [Abstract][Full Text] [Related]
30. Acute opioid physical dependence in humans: effects of varying the morphine-morphine interval. Kirby KC; Stitzer ML NIDA Res Monogr; 1990; 105():449-50. PubMed ID: 1876071 [No Abstract] [Full Text] [Related]
31. Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Matsuzawa S; Suzuki T; Misawa M Alcohol Clin Exp Res; 2000 Mar; 24(3):366-72. PubMed ID: 10776678 [TBL] [Abstract][Full Text] [Related]
32. A deficit in one-trial context fear conditioning is not due to opioid analgesia. Bevins RA; Ayres JJ Pharmacol Biochem Behav; 1994 Sep; 49(1):183-6. PubMed ID: 7816871 [TBL] [Abstract][Full Text] [Related]
33. The physical dependence liability of butorphanol: a comparative study with morphine. Horan P; Ho IK Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord. Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144 [TBL] [Abstract][Full Text] [Related]
35. Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse. Moulédous L; Díaz MF; Gutstein HB Pharmacol Biochem Behav; 2007 Nov; 88(1):39-46. PubMed ID: 17764731 [TBL] [Abstract][Full Text] [Related]
36. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine. Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361 [TBL] [Abstract][Full Text] [Related]
37. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
38. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats. Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735 [TBL] [Abstract][Full Text] [Related]
39. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues. Baker KD; McNally GP; Richardson R Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284 [TBL] [Abstract][Full Text] [Related]
40. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]